focus -WSS

focus

author：focus 2025-09-27 23:53:31 - browse：59

Pascal Soriot 2019 — Pascal Soriot has served as CEO of AstraZeneca since 2012. Win McNamee/Getty Images

CAMBRIDGE, England — On a bit of a roll, AstraZeneca on Tuesday laid out ambitious growth goals for the rest of the decade, seeking to build on its momentum in fields like oncology as it said it would nearly double its revenue to $80 billion by 2030.

Hitting such a target would depend on the launch of 20 new medicines and continued growth of its cancer and rare disease therapies, as well as other drugs. It would also require outpacing the targets laid out by AstraZeneca’s large pharma peers.

But at an investor day here at the company’s shiny new Discovery Centre, CEO Pascal Soriot opened his presentation by bringing up the goal set by the company a decade ago — $45 billion in revenue by 2023. The company faced some declines early in that period, but after surging in the past few years, it hit that target, bringing in $45.8 billion last year. Its recent growth has also propelled the company’s share price.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： A Theranos scientist

explore

WSS

Campaign finance charge dropped from case against Sam Bankman

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

What AstraZeneca

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Doctors in states that ban abortion can still help patients

A Theranos scientist

leisure time

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Why you get paid to donate plasma but not blood

Drug repurposing or repositioning? The language matters

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Jerome Adams on the need for new antivirals for Covid

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Peter Hotez and the public health issue of online harassment

Europe is fastest

In age of alternative facts, a scholarly course on calling out crap

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

knowledge

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

HCA says smaller share of spending going to labor

Biden administration sends mixed signals on US soldier who crossed into North Korea

5 wounded, 2 critically, in Michigan shopping center shooting

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

explore

knowledge

knowledge

Wikipedia